The Powerful and Evolving Role of Patient Advocacy Groups in Orphan Drug Development

A major goal of patient advocacy groups is to address the unmet needs of patients with cancer or rare diseases by providing access to the most effective drugs. In recent years, patient advocacy groups have expanded their influence over the drug development continuum from discovery to approval to market entry. Many groups directly fund, help design, or recruit patients to participate in clinical trials.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Advanced Immunoprecipitation

Abcam

Identifying bona fide protein-protein interactions can be a difficult task due to the complexity of protein interactions. Immunoprecipitation of proteins can elucidate the molecular importance protein-protein interactions play in signal transduction. Join our presenters as they discuss how to identify protein interactions through immunoprecipitation and overcome biochemical problems that can be associated with this technique.
Watch Now

Designing Amorphous Dispersion Formulations for Poorly Soluble Drugs

Pharmtech

Many orally administered small molecules have low aqueous solubility, which leads to poor oral absorption. For many of these poorly soluble drugs currently in development, amorphous dispersions are increasingly being used as a formulation approach to improve solubility and oral absorption.
Watch Now

The Kinetics of Drug Binding

news-medical

Optimizing the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems.
Watch Now

Understanding the Evolution of Intranasal Vaccines

Intranasal vaccination is an interesting and increasingly attractive alternative to improving the delivery of therapeutic vaccines. It comes with the promise of better efficacy by stimulating local mucosal response, needle-free delivery and could be self-administrable.
Watch Now